Nothing Special   »   [go: up one dir, main page]

Tornehave et al., 1987 - Google Patents

Placental proteins in peripheral blood and tissues of ectopic pregnancies

Tornehave et al., 1987

Document ID
15529886086046637417
Author
Tornehave D
Chemnitz J
Westergaard J
Teisner B
Poulsen H
Bolton A
Grudzinskas J
Publication year
Publication venue
Gynecologic and obstetric investigation

External Links

Snippet

Circulating human chorionic gonadotrophin (hCG), Schwangerschaftsprotein 1 (SP-1) and pregnancy-associated plasma protein A (PAPP-A) were examined in 10 women with ectopic gestation in relation to distribution and intensity of staining for these molecules using …
Continue reading at karger.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Similar Documents

Publication Publication Date Title
Radwanska et al. Plasma progesterone levels in normal and abnormal early human pregnancy
Pellicer et al. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels
Julkunen et al. Placental protein 14 and progestagen-dependent endometrial protein are immunologically indistinguishable
Hofmann et al. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy
Klentzrics et al. Placental protein 14 in cycles with normal and retarded endometrial differentiation
Gaucherand et al. Comparative study of three amniotic fluid markers in premature rupture of membranes: fetal fibronectin, alpha‐fetoprotein, diamino‐oxydase
Goldstein et al. Correlation between estradiol and progesterone in cycles with luteal phase deficiency
LA VECCHIA et al. Incessant ovulation and ovarian cancer: a critical approach
SPELLACY et al. Human placental lactogen levels in multiple pregnancies
Yovich et al. The Prognostic Value of HCG, PAPP‐A, Oestradiol‐170 and Progesterone in Early Human Pregnancy
Tornehave et al. Placental proteins in peripheral blood and tissues of ectopic pregnancies
Critchley et al. Serum PP14 levels in a patient with Turner's syndrome pregnant after frozen embryo transfer
Matorras et al. Infertile women with and without endometriosis: a case control study of luteal phase and other infertility conditions
Kauma et al. Immunoperoxidase localization of prolactin in endometrium during normal menstrual, luteal phase defect, and corrected luteal phase defect cycles
Johnson et al. Placental and ovarian hormones in anembryonic pregnancy
Fay et al. A biochemical test for the direct assessment of endometrial function: measurement of the major secretory endometrial protein PP14 in serum during menstruation in relation to ovulation and luteal function
Bar-Hava et al. Pregnancy: Triple-test screening in in vitro fertilization pregnancies
Chemnitz et al. Comparison of different antibody preparations against pregnancy‐associated plasma protein‐A (PAPP‐A) for use in localization and immunoassay studies
Joshi Progestin-dependent human endometrial protein: a marker for monitoring human endometrial function
Moghissi et al. Cyclic changes of cervical mucus enzymes related to the time of ovulation: I. Alkaline phosphatase
Seppälä et al. The use of hCG and other pregnancy proteins in the diagnosis of ectopic pregnancy
Westergaard et al. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI
Chemnitz et al. The localization of pregnancy proteins (hPL, SP1 and PAPP-A) in intra-and extrauterine pregnancies
Turhan et al. Studies on direct intraperitoneal insemination in the management of male factor, cervical factor, unexplained and immunological infertility
Than et al. Serum PP12, PP14, SP1 and hCG values in the 28 days after the LH-surge in patients who do and do not conceive after artificial insemination or in vitro fertilization